2013
DOI: 10.1016/s1873-9946(13)60449-3
|View full text |Cite
|
Sign up to set email alerts
|

P428 New opportunities overcoming of the secondary inefficiencies of the anticytokine therapy in patients with inflammatory bowel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2014
2014
2015
2015

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…The level of anticytokine drugs antibodies was shown to correlate with the severity of clinical and endoscopic picture [12]. CT was also reported to decrease the need for glucocorticosteroid therapy and other drugs, what results in the decrease of treatment cost [28].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The level of anticytokine drugs antibodies was shown to correlate with the severity of clinical and endoscopic picture [12]. CT was also reported to decrease the need for glucocorticosteroid therapy and other drugs, what results in the decrease of treatment cost [28].…”
Section: Discussionmentioning
confidence: 99%
“…The efficiency of conventional methods of UC and CD treatment leaves much to be desired [1,[9][10][11]. Modern therapy of IBD includes biological therapy (antibodies to TNF-α, adhesion molecules, IL-12/23, IL-6R, endoscopic application of artificially grown pieces of tissues etc) and gene therapy (iRNA-technologies aimed at inhibition of the necessary genes) [2,3,7,12,13]. The application of nanoparticles for the transportation of drugs despite its high cost is also promising [2].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, the 1 and 2 phases of clinical studies have confirmed the safety of cell therapy in the treatment of the colon disorders and its advantages over the use of fibrin glue in patients with fistulas [31,33]. As mentioned above, cell therapy is particularly important for patients refractory to anticytokine drugs [14].…”
Section: Cell Therapy In the Treatment Of Ulcerative Colitis And Crohmentioning
confidence: 92%
“…Also cell therapy is considered to be the next generation of therapeutic interventions in the treatment of systemic inflammatory diseases of the colon, especially for patients with secondary resistance to anticytokine therapy [14,22]. Today significant clinical experience of stem cells application in the treatment of liver failure and pancreatic disorders as well as genetically mediated diseases of the intestine, including celiac disease has been accumulated [5,11,16,24,29].…”
mentioning
confidence: 99%